Skip to main content

Atypical Alzheimer’s Disease, Mixed Dementia, and Amyloid Angiopathy

  • Chapter
  • First Online:
Neuro-Geriatrics

Abstract

Alzheimer’s disease typically presents with episodic, short-term memory impairment. There are three principle variants or atypical forms of Alzheimer’s disease: (1) posterior cortical atrophy, (2) logopenic aphasia, and (3) frontal Alzheimer’s disease. Each of these syndromes has a characteristic phenotype that can be identified clinically. Each of the phenotypes can be caused by other neurological disorders besides Alzheimer’s disease and differential diagnosis is an important part of the approach to neurological care. Mixed dementias are common, particularly the association of Alzheimer’s disease with cerebrovascular disease. Mixed dementia may also occur with Alzheimer’s disease in combination with Lewy body pathology and TDP-43 protein inclusions. Amyloid angiopathy is a vascular disorder with amyloid accumulation in the blood vessels and usually presenting with lobar hemorrhage. When there is prominent inflammation, patients may improve with treatment with steroids or anti-metabolites.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

References

  1. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734–46.

    Article  PubMed  Google Scholar 

  2. Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017. doi:10.1016/j.jalz.2017.01.014.

  3. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–14.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Johnson JK, Head E, Kim R, Starr A, Cotman CW. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol. 1999;56(10):1233–9.

    Article  CAS  PubMed  Google Scholar 

  5. Tekin S, Mega MS, Masterman DM, Chow T, Garakian J, Vinters HV, et al. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol. 2001;49(3):355–61.

    Article  CAS  PubMed  Google Scholar 

  6. Larner AJ. “Frontal variant Alzheimer’s disease”: a reappraisal. Clin Neurol Neurosurg. 2006;108(7):705–8.

    Article  PubMed  Google Scholar 

  7. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–29.

    Article  PubMed  Google Scholar 

  8. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250–60.

    Article  CAS  PubMed  Google Scholar 

  9. Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc. 1999;47(5):564–9.

    Article  CAS  PubMed  Google Scholar 

  10. Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, et al. Amyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11(3):241–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537–9.

    Article  CAS  PubMed  Google Scholar 

  12. Auriel E, Charidimou A, Gurol ME, Ni J, Van Etten ES, Martinez-Ramirez S, et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2016;73(2):197–202.

    PubMed  Google Scholar 

  13. Kinnecom C, Lev MH, Wendell L, Smith EE, Rosand J, Frosch MP, et al. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2007;68(17):1411–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

Dr. Cummings has provided consultation to Abbvie, Acadia, Accera, Actinogen, ADAMAS, Alkahest, Alzheon, Anavex, Astellas, Astra Zeneca, Avanir, Axovant, Biogen-Idec, Biotie, Boehinger-Ingelheim, Chase, Eisai, Forum, GE Healthcare, Genentech, Grifols, Intracellular Therapies, IRIS, Ionis Pharmaceuticals, Lilly, Lundbeck, MedAvante, Merck, Neurotrope, Novartis, Nutricia, Otsuka, Pfizer, Probiodrug, QR Pharma, Resverlogix, Roche, Servier, Sunovion, Suven, Takeda, Toyoma, Transition Therapeutics, and United Neuroscience companies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey Cummings M.D., Sc.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Cummings, J. (2017). Atypical Alzheimer’s Disease, Mixed Dementia, and Amyloid Angiopathy. In: Tousi, B., Cummings, J. (eds) Neuro-Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-319-56484-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56484-5_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56483-8

  • Online ISBN: 978-3-319-56484-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics